Studies have shown that olfactory epithelial cells express high levels of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) [61–63], which could provide a plausible explanation for COVID-19-related anosmia (Fig. 1). Here, ACE2 is linked to Kallmann syndrome.